Catheter Precision announces 1-for-19 reverse stock split effective August 15, 2025

Catheter Precision, Inc.

Reverse split ratio of 1-for-19 approved by board after shareholder authorization at July 25 annual meeting.
Pre-split shares reduced from ~23.3M to ~1.2M; no fractional shares issued, cash paid instead.
Split intended to maintain NYSE American minimum bid price requirement; CUSIP changes to 74933X708.
Annual meeting also approved issuance of up to 4.29M shares upon Series L warrant exercise and up to 8.57M shares on Series B preferred conversion.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.